Skip to main content

Merit Medical Systems to Announce Third Quarter Results on October 28, 2020 and Host “Foundations for Growth” Investor Call on November 10, 2020

Written by Customer Service on . Posted in Public Companies.

SOUTH JORDAN, Utah, Oct. 09, 2020 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the third fiscal quarter ended September 30, 2020, after the close of the stock market on Wednesday, October 28, 2020. The Company also announced plans to host an investor call after the close of the stock market on Tuesday, November 10, 2020.Management will host an investor conference call on Wednesday, October 28, 2020 at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific) to discuss the results of the quarter and provide a corporate update with a question-and-answer session. Those who would like to participate may dial 844-578-9672 (508-637-5656 for international callers) and provide the conference ID 3195654.A live webcast of the call will also be available on the investor relations section of the Company’s website at www.merit.com.For those unable to participate, a replay of the call will be available for two weeks at 855-859-2056 (404-537-3406 for international callers); conference ID 3195654. The webcast will be archived on the investor relations section of the Company’s website at www.merit.com.
Management will host an investor call, “Foundations for Growth”, on Tuesday, November 10, 2020 at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific) to introduce the Company’s multi-year financial targets for growth and improved profitability and will host a question-and-answer session.Those who would like to participate may dial 844-578-9672 (508-637-5656 for international callers) and provide the conference ID 2887092.A live webcast of the call will also be available on the investor relations section of the Company’s website at www.merit.com.For those unable to participate, a replay of the call will be available for two weeks at 855-859-2056 (404-537-3406 for international callers); conference ID 2887092. The webcast will be archived on the investor relations section of the Company’s website at www.merit.com.
ABOUT MERITFounded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 500 individuals. Merit employs approximately 6,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.CONTACTS:Teresa Johnson
Corporate Communications
(801) 208-4295 (office)
tjohnson@merit.comPatrick McCarty
Investor Relations
(801) 208-4581 (office)
patrick.mccarty@merit.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.